Technique to make CAR T-cells in vivo could transform cancer care
In current years, chimeric antigen receptor (CAR) T-cell remedy has modified outcomes for sufferers with aggressive blood cancers that not reply to customary therapies. In some acute leukaemias, CAR T-cell


